Get started
Author

Julia Hamati

Observed name: Hamati, Julia
OpenAlex ID: A5119831982
Paltusotine versus octreotide: different effects on radioligand uptake in neuroendocrine tumours
2025 · Katharina Wang, Christoph J Auernhammer, et al. · Endocrine Oncology · 2
Personalized Drug Screening and Risk Assessment in Patient-Derived Gastroenteropancreatic Neuroendocrine Neoplasms
2026 · Christoph J Auernhammer, Katharina Wang, et al. · The Journal of Clinical Endocrinology & Metabolism · 1
Supplementary data: Personalized drug screening and risk assessment in patient-derived gastroenteropancreatic neuroendocrine neoplasms
2025 · Auernhammer, Christoph J, Wang, Katharina, et al. · Universitätsbibliothek der LMU · 1
Effects of a GLP-1 agonist and anti-diabetic therapies on pheochromocytoma/paraganglioma growth
2026 · Katharina Wang, Priska Stempfle, et al. · Endocrine Related Cancer
EP1108 - ECE_2149 - Nicotinamide phosphoribosyltransferase (NAMPT) inhibition—a novel metabolically-guided personalised therapy for neuroendocrine neoplasia
2026 · Katharina Wang, Julia Hamati, et al. · European Journal of Endocrinology
PDF
Works count: 5
Citation count: 4
H-index: 1
I10-index:
Year
Topic
Type